CME falls after Argus cuts rating to 'hold' on muted contract‑volume outlook

Shares of U.S. derivatives exchange operator CME CME.O fall 2.05% to $318.48 after Argus Research downgrades CME to "hold" from "buy"

Cites, "We expect muted growth for equity index, metals, cryptocurrency, and micro contracts for retail investors offset by gains in agriculture and prediction markets"

Adds, shares surpassed our prior target of $295 and we see limited upside

"We see mid-single-digit growth in interest-rate contract volume at CME as stubborn inflation, tariffs, and geopolitical concerns stay at the forefront in 2026" - Argus

Seven of 16 analysts rate stock "strong buy" or "buy", six "hold" and three "sell"; their median PT is $312 - data compiled by LSEG

Including session's move, CME up 17.16% YTD